Microbial Innovation for Drug Discovery

Nosopharm – a Young Innovative Company in biotechnology – aims to exploit the exceptional medicinal potential of the microbial biodiversity. Thus, Nosopharm develops a biotechnological platform of microbial mining that affords the discovery and the development of new therapeutic molecules.

By mean of this platform, Nosopharm takes up the challenge to discover novel antibiotics to cope with the most worrisome nosocomial (hospital-acquired) infections